高级检索
当前位置: 首页 > 详情页

Review of 1375 enucleations in the TongRen Eye Centre, Beijing

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Univ Med Sci, Beijing TongRen Hosp, Beijing TongRen Eye Ctr, Beijing Inst Ophthalmol, Beijing, Peoples R China [2]Heidelberg Univ, Fac Clin Med Mannheim, Dept Ophthalmol, D-6800 Mannheim, Germany
出处:
ISSN:

关键词: ocular enucleation ocular trauma ocular tumour phthisis bulbi retinoblastoma

摘要:
Purpose To review clinical causes for ocular enucleations and the histopathological features of the enucleated globes in a large third-referral centre in China. Methods The retrospective study included 1375 globes enucleated in the Beijing TongRen Hospital between January 2003 and November 2006. The medical records were reviewed, and the clinical indications for enucleation and histopathological findings were evaluated. Results The enucleated eyes accounted for 0.97% of all operated patients registered in the hospital and for 29.5% of all surgical specimens received in the pathological department. The age distribution showed two peaks at an age group of 0-10 years (main enucleation cause: retinoblastoma) and at an age group of 30-40 years (main cause: trauma). In the whole study group, trauma was the most common clinical diagnosis (62.5%) leading to enucleation, followed by tumours (28.5%), surgically treated or untreated ocular diseases (5.7%), and infectious or inflammatory diseases (1.7%). With respect to the histopathological findings, phthisis bulbi (36.4%) was the most frequent finding followed by ocular malignant tumours (28.5%), and acute severe ocular injury (19.9%). Uveal metastases were the second most common intraocular malignant tumour in adults, in the majority of globes secondary to a primary lung cancer. Conclusions The rate of 1% of enucleations per patient operated and the relatively high rate of ocular traumata as primary cause for enucleation suggest to improve further safety conditions and primary surgical care. The relatively high rate of ocular tumours as cause for enucleations suggests to promote the wide-spread clinical introduction chemoradioactive tumour therapy.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2007]版:
大类 | 4 区 医学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 眼科学
JCR分区:
出版当年[2006]版:
Q2 OPHTHALMOLOGY
最新[2023]版:
Q2 OPHTHALMOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2006版] 出版当年五年平均 出版前一年[2005版] 出版后一年[2007版]

第一作者:
第一作者机构: [1]Capital Univ Med Sci, Beijing TongRen Hosp, Beijing TongRen Eye Ctr, Beijing Inst Ophthalmol, Beijing, Peoples R China
通讯作者:
通讯机构: [1]Capital Univ Med Sci, Beijing TongRen Hosp, Beijing TongRen Eye Ctr, Beijing Inst Ophthalmol, Beijing, Peoples R China [*1]Beijing Inst Ophthalmol, 17 Hougou Lane,Chong Nei St, Beijing 100005, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21279 今日访问量:1 总访问量:1220 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)